Language selection

Government of Canada

Search

Details for: PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Company: HIKMA CANADA LIMITED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02401312PIPERACILLIN AND TAZOBACTAM FOR INJECTIONPIPERACILLIN (PIPERACILLIN SODIUM); TAZOBACTAM (TAZOBACTAM SODIUM)2 G / VIAL; 0.25 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02401320PIPERACILLIN AND TAZOBACTAM FOR INJECTIONTAZOBACTAM (TAZOBACTAM SODIUM); PIPERACILLIN (PIPERACILLIN SODIUM)0.375 G / VIAL; 3 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02401339PIPERACILLIN AND TAZOBACTAM FOR INJECTIONPIPERACILLIN (PIPERACILLIN SODIUM); TAZOBACTAM (TAZOBACTAM SODIUM)4 G / VIAL; 0.5 G / VIALPOWDER FOR SOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Piperacillin Containing Products (alone or in combination with tazobactam) - Assessing the Potential Risk of Drug Reaction/Rash with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: